🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the best dose and safety of Bcl-2 inhibitor ...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2015-08-03
Trial ID
NCT02427451
This phase III trial compares adding a new anti-cancer drug (venetoclax) to...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-01-31
Trial ID
NCT03737981
Treatments Being Tested
Richter's syndrome (RS) is a life-threatening complication of chronic lymph...
Status
Completed
Location
Bnai Zion Medical Center
Start Date
2021-08-08
Trial ID
NCT04939363
Treatments Being Tested
An observational study to assess the effectiveness, health economic-relevan...
Status
Recruiting
Location
Universitaetsklinikum St. Poelten /ID# 221152
Start Date
2017-12-04
Trial ID
NCT03342144
Background: Aggressive B-cell lymphomas can be cured but people with disea...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2021-07-09
Trial ID
NCT04739813
Treatments Being Tested
This phase III trial studies how well ibrutinib and obinutuzumab with or wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-02-12
Trial ID
NCT03701282
Safety, pharmacokinetics, and preliminary efficacy of CC-122 alone and in c...
Status
Completed
Location
University of California San Diego
Start Date
2015-07-27
Trial ID
NCT02406742
Treatments Being Tested
The aim of this study is to evaluate if standard chemoimmunotherapy (FCR, B...
Status
Completed
Location
Medizinische Universitaet Wien
Start Date
2016-12-13
Trial ID
NCT02950051
Treatments Being Tested
Background: Chronic Lymphocytic Leukemia (CLL) is the most common leukemia ...
Status
Completed
Location
Grupo Cooperativo de Hemopatías Malignas
Start Date
2018-12-01
Trial ID
NCT03755947
Treatments Being Tested
This phase II trial studies how well obinutuzumab, ibrutinib, and venetocla...
Status
Active Not Recruiting
Location
University of California, San Francisco (UCSF) Fresno
Start Date
2021-02-24
Trial ID
NCT04450173
Treatments Being Tested